Galectin Therapeutics (FRA:PHPN) Accounts Payable : €5.90 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Galectin Therapeutics Accounts Payable?

Galectin Therapeutics's Accounts Payable for the quarter that ended in Dec. 2023 was €5.90 Mil.

Galectin Therapeutics's quarterly Accounts Payable increased from Jun. 2023 (€1.82 Mil) to Sep. 2023 (€2.51 Mil) and increased from Sep. 2023 (€2.51 Mil) to Dec. 2023 (€5.90 Mil).

Galectin Therapeutics's annual Accounts Payable increased from Dec. 2021 (€1.60 Mil) to Dec. 2022 (€3.67 Mil) and increased from Dec. 2022 (€3.67 Mil) to Dec. 2023 (€5.90 Mil).

Galectin Therapeutics Accounts Payable Historical Data

The historical data trend for Galectin Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galectin Therapeutics Accounts Payable Chart

Galectin Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

1.50

1.06

1.60

3.67

5.90

Galectin Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															3.67	2.39	1.82	2.51	5.90

Galectin Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Galectin Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Galectin Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Galectin Therapeutics (FRA:PHPN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galectin Therapeutics Inc (FRA:PHPN) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

GALT:USA

Address

4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071

Website

https://www.galectintherapeutics.com

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Galectin Therapeutics (FRA:PHPN) Headlines

No Headlines